Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21355532rdf:typepubmed:Citationlld:pubmed
pubmed-article:21355532lifeskim:mentionsumls-concept:C0259969lld:lifeskim
pubmed-article:21355532lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:21355532lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:21355532lifeskim:mentionsumls-concept:C0678610lld:lifeskim
pubmed-article:21355532lifeskim:mentionsumls-concept:C1101232lld:lifeskim
pubmed-article:21355532pubmed:issue7lld:pubmed
pubmed-article:21355532pubmed:dateCreated2011-3-25lld:pubmed
pubmed-article:21355532pubmed:abstractTextThe intramolecular 1,3-chirality transfer reaction of chiral amino alcohols 1 with 99% ee was developed to construct chiral 1-substituted tetrahydroisoquinoline 2. Bi(OTf)(3) (10 mol %)-catalyzed cyclization of 1 (R = H) afforded (S)-1-(E)-propenyl tetrahydroisoquinoline 2 (R = H) in 83% yield with a ratio of 98:2. The stereochemistry at the newly formed chiral center was produced by a syn S(N)2'-type process. In this reaction, the substituent on the benzene ring of 1 significantly affected the reactivities and selectivities. A plausible reaction mechanism was proposed.lld:pubmed
pubmed-article:21355532pubmed:languageenglld:pubmed
pubmed-article:21355532pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21355532pubmed:citationSubsetIMlld:pubmed
pubmed-article:21355532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21355532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21355532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21355532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21355532pubmed:statusMEDLINElld:pubmed
pubmed-article:21355532pubmed:monthAprlld:pubmed
pubmed-article:21355532pubmed:issn1520-6904lld:pubmed
pubmed-article:21355532pubmed:authorpubmed-author:KawaiNobuyuki...lld:pubmed
pubmed-article:21355532pubmed:authorpubmed-author:UenishiJun'ic...lld:pubmed
pubmed-article:21355532pubmed:authorpubmed-author:MatsudaMikaMlld:pubmed
pubmed-article:21355532pubmed:authorpubmed-author:AbeRyuzouRlld:pubmed
pubmed-article:21355532pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21355532pubmed:day1lld:pubmed
pubmed-article:21355532pubmed:volume76lld:pubmed
pubmed-article:21355532pubmed:ownerNLMlld:pubmed
pubmed-article:21355532pubmed:authorsCompleteYlld:pubmed
pubmed-article:21355532pubmed:pagination2102-14lld:pubmed
pubmed-article:21355532pubmed:meshHeadingpubmed-meshheading:21355532...lld:pubmed
pubmed-article:21355532pubmed:meshHeadingpubmed-meshheading:21355532...lld:pubmed
pubmed-article:21355532pubmed:meshHeadingpubmed-meshheading:21355532...lld:pubmed
pubmed-article:21355532pubmed:meshHeadingpubmed-meshheading:21355532...lld:pubmed
pubmed-article:21355532pubmed:meshHeadingpubmed-meshheading:21355532...lld:pubmed
pubmed-article:21355532pubmed:meshHeadingpubmed-meshheading:21355532...lld:pubmed
pubmed-article:21355532pubmed:meshHeadingpubmed-meshheading:21355532...lld:pubmed
pubmed-article:21355532pubmed:year2011lld:pubmed
pubmed-article:21355532pubmed:articleTitleSynthesis of chiral 1-substituted tetrahydroisoquinolines by the intramolecular 1,3-chirality transfer reaction catalyzed by Bi(OTf)3.lld:pubmed
pubmed-article:21355532pubmed:affiliationKyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto 607-8412, Japan. kawai@mb.kyoto-phu.ac.jplld:pubmed
pubmed-article:21355532pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21355532pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed